+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioCryst Pharmaceuticals Inc - logo

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 230 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 131 Pages
  • Global
From
Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders and Rare Disorders), Route of Administration (Intravenous and Oral) and Geography (North America, Europe and Asia Pacific), 2021-2035 - Product Thumbnail Image

Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders and Rare Disorders), Route of Administration (Intravenous and Oral) and Geography (North America, Europe and Asia Pacific), 2021-2035

  • Report
  • January 2022
  • 212 Pages
  • Global
From
Fertility Drugs Global Market Report 2024 - Product Thumbnail Image

Fertility Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria (PNH) Global Market Report 2024 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures - Product Thumbnail Image

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

  • Report
  • May 2019
  • 385 Pages
  • Global
From
Plasma Protease C1 Inhibitor Market 2024-2028 - Product Thumbnail Image

Plasma Protease C1 Inhibitor Market 2024-2028

  • Report
  • January 2024
  • 166 Pages
  • Global
From
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2024 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • February 2022
  • 131 Pages
  • Global
From
Autoimmune Treatment Global Market Report 2024 - Product Thumbnail Image

Autoimmune Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
ACVR1 protein inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

ACVR1 protein inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 146 Pages
  • Global
From
Plasma Protease C1-inhibitor Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Plasma Protease C1-inhibitor Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 110 Pages
  • Global
From
Fibrodysplasia Ossificans Progressiva (FOP) Pipeline Analysis 2019 (H1) - Product Thumbnail Image

Fibrodysplasia Ossificans Progressiva (FOP) Pipeline Analysis 2019 (H1)

  • Report
  • May 2019
  • 80 Pages
  • Global
From
Influenza Vaccination Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Influenza Vaccination Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2022
  • 72 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 127 Pages
  • Global
From
BioCryst Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

BioCryst Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Comprehensive Report on BioCryst Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on BioCryst Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator